IBIO vs IVZ · rev $100.0K vs rev $3.57B
iBio, Inc. Common Stock (IBIO) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
IBIO currently screens at market cap $13.4M. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the IBIO and IVZ stock pages for the full models.
Not investment advice.